Aurinia Pharmaceuticals (AUPH) Earnings Date & Reports

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AUPH is expected to report earnings to rise 950.00% to 10 cents per share on May 01

Aurinia Pharmaceuticals AUPH Stock Earnings Reports

Q1'25

Est.

$0.10

Q4'24

Missed

by $0.02

Q3'24

Beat

by $0.08

Q2'24

Est.

$0.01

Q1'24

Beat

by $0.07

The last earnings report on February 27 showed earnings per share of 0 cents, missing the estimate of 2 cents. With 551.02K shares outstanding, the current market capitalization sits at 1.08B.

View a ticker or compare two or three

Compare

AUPH